Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Emerging Role of Flavonoids in Autism Spectrum Disorder: A Systematic Review
Rosa Savino, Alessandro Medoro, Sawan Alì, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3520-3520
Open Access | Times Cited: 11

Showing 11 citing articles:

Polyphenols Targeting NF-κB Pathway in Neurological Disorders: What We Know So Far?
Abdullah Al Mamun, Chuxiao Shao, Peiwu Geng, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1332-1355
Open Access | Times Cited: 23
Luteolin for neurodegenerative diseases: a review
Dunuvilla Kavindi Jayawickreme, Cletus Ekwosi, Apurva Anand, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 644-664
Open Access | Times Cited: 13
Cannabinoid treatment for the symptoms of autism spectrum disorder
Adi Aran, Dalit Cayam Rand
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 1, pp. 65-79
Closed Access | Times Cited: 5
Nobiletin and Eriodictyol Suppress Release of IL-1β, CXCL8, IL-6, and MMP-9 from LPS, SARS-CoV-2 Spike Protein, and Ochratoxin A-Stimulated Human Microglia
Irene Tsilioni, Duraisamy Kempuraj, Theoharis C. Theoharides
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 636-636
Open Access
Polyphenols, Alkaloids, and Terpenoids Against Neurodegeneration: Evaluating the Neuroprotective Effects of Phytocompounds Through a Comprehensive Review of the Current Evidence
Enzo Pereira de Lima, Lucas Fornari Laurindo, Vitor Cavallari Strozze Catharin, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 124-124
Open Access
Dietary flavonoids modulate the gut microbiota: A new perspective on improving autism spectrum disorder through the gut-brain axis
H Dai, Yuhan Jiang, Shuxun Liu, et al.
Food Research International (2024) Vol. 186, pp. 114404-114404
Closed Access | Times Cited: 4
Apigenin Alleviates Autistic-like Stereotyped Repetitive Behaviors and Mitigates Brain Oxidative Stress in Mice
Petrilla Jayaprakash, Dmytro Isaev, Keun‐Hang Susan Yang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 482-482
Open Access | Times Cited: 2
Herbal Medicine Approach and their Effectiveness in the Management of Autism Spectrum Disorders
Samir Abdulkarim Alharbi
Research Journal of Pharmacy and Technology (2024), pp. 3459-3466
Closed Access
Molecular Docking Analysis Reveals the Promising Role of Apigenin as a Potential Treatment for Neurological Disorders
Muhammad Wasim, Syeda Rehana Zia, Saara Ahmad
Clinical Neuropharmacology (2024)
Closed Access
Enhancing Flavonoid Enrichment via Supramolecular: A Study on the Material Basis of Sanguisorbae Radix after Carbonizing by Stir-Frying
Feng Li, Hong-Dan Wu, Ruixiao Ma, et al.
LWT (2024), pp. 117192-117192
Open Access
Compostos Bioativos nos Transtornos do Espectro Autista: Revisão de Literatura
Gabriela Datsch Bennemann, Caryna Eurich Mazur, Daniela Miotto Bernardi, et al.
Mérida Publishers eBooks (2023), pp. 8-36
Open Access
Page 1

Scroll to top